Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze BCYC stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BCYC investment potential.

What is BCYC stock price today?

Get real-time BCYC stock price, historical data, and price charts on Financhill. Track BCYC performance with our advanced analysis tools.

Is BCYC a good investment?

Evaluate BCYC investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BCYC stock?

To buy BCYC stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BCYC?

View detailed market capitalization data and company valuation metrics for BCYC on our comprehensive analysis page.

What is the P/E ratio of BCYC?

Use our fundamental analysis tools to view BCYC P/E ratio and compare valuation metrics with industry peers.

What are BCYC earnings?

View BCYC earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Bicycle Therapeutics Plc Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

BCYC
Bicycle Therapeutics Plc

Last Price:

$7.16

Seasonality Move:

11.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

Bicycle Therapeutics Plc Stock Forecast

Over the next 52 weeks, Bicycle Therapeutics Plc has on average historically risen by 40.8% based on the past 6 years of stock performance.
Bicycle Therapeutics Plc has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Bicycle Therapeutics Plc Stock Undervalued?

The current Bicycle Therapeutics Plc [BCYC] share price is $7.14. The Score for BCYC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
BCYC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Bicycle Therapeutics Plc Stock Go Up Next Year?

Over the next 52 weeks, Bicycle Therapeutics Plc has on average historically risen by 40.8% based on the past 6 years of stock performance.

Bicycle Therapeutics Plc Stock Rating

Sell

Bicycle Therapeutics Plc (BCYC) is a Sell

Is Bicycle Therapeutics Plc overpriced?

Bicycle Therapeutics Plc has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Bicycle Therapeutics Plc Stock Price History

Is BCYC stock going to rise?

The current trend is relatively stagnant and BCYC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United Kingdom

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

bicycletherapeutics.com

52-Week Data

52-Week High:

21.50

52-Week Low:

6.03

Prediction Charts

Market Cap:

495.3M

Price in USD:

7.14

Volume:

272.9K

Beta:

0.88

Technical Analysis

SMA50:

7.50

SMA100:

7.51

SMA200:

8.06

52-Wk Change:

-63.29%

Stock Predictions

Is Bicycle Therapeutics Plc stock public?

Yes, Bicycle Therapeutics Plc is a publicly traded company.
What is the Bicycle Therapeutics Plc stock quote today?

The Bicycle Therapeutics Plc stock price is 7.14 USD today.
How to buy Bicycle Therapeutics Plc stock online?

You can buy Bicycle Therapeutics Plc shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-13	6.60	6.60	6.89	6.47
Nov-14	6.49	6.48	6.75	6.43
Nov-17	6.50	6.46	6.67	6.30
Nov-18	6.40	6.47	6.59	6.17
Nov-19	6.46	6.25	6.68	6.18
Nov-20	6.25	6.17	6.75	6.06
Nov-21	6.13	6.32	6.40	6.03
Nov-24	6.30	6.74	6.79	6.30
Nov-25	6.74	6.87	6.97	6.71
Nov-26	6.83	7.31	7.36	6.76
Nov-28	7.27	7.48	7.83	7.27
Dec-1	7.37	7.04	7.40	7.00
Dec-2	7.00	6.87	7.09	6.84
Dec-3	6.85	7.14	7.17	6.76

Bicycle Therapeutics Plc Earnings

Bicycle Therapeutics Plc Earnings Report: Per Share Bicycle Therapeutics Plc Earnings Q1 Q2 Q3 and Q4 last year and next year.

Bicycle Therapeutics Plc Forecast Revenue Growth

Bicycle Therapeutics Plc Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics Plc and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.82 per share, and an increase next year of $0.29 per share.

* Bicycle Therapeutics Plc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.